Omega Other Current Liab from 2010 to 2024

OHI Stock  USD 39.81  0.80  1.97%   
Omega Healthcare's Other Current Liabilities is increasing with slightly volatile movements from year to year. Other Current Liabilities is estimated to finish at about 248.3 M this year. For the period between 2010 and 2024, Omega Healthcare, Other Current Liabilities quarterly trend regression had median of  248,332,350 and r-value of  0.63. View All Fundamentals
 
Other Current Liabilities  
First Reported
1992-12-31
Previous Quarter
667.9 M
Current Value
313.4 M
Quarterly Volatility
191 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Omega Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Omega Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 335.7 M, Interest Expense of 247.3 M or Selling General Administrative of 85.6 M, as well as many indicators such as Price To Sales Ratio of 5.5, Dividend Yield of 0.1 or PTB Ratio of 1.26. Omega financial statements analysis is a perfect complement when working with Omega Healthcare Valuation or Volatility modules.
  
Check out the analysis of Omega Healthcare Correlation against competitors.

Latest Omega Healthcare's Other Current Liab Growth Pattern

Below is the plot of the Other Current Liab of Omega Healthcare Investors over the last few years. It is Omega Healthcare's Other Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Omega Healthcare's overall financial position and show how it may be relating to other accounts over time.
Other Current Liab10 Years Trend
Slightly volatile
   Other Current Liab   
       Timeline  

Omega Other Current Liab Regression Statistics

Arithmetic Mean227,027,890
Coefficient Of Variation44.52
Mean Deviation79,817,245
Median248,332,350
Standard Deviation101,074,057
Sample Variance10216T
Range374.6M
R-Value0.63
Mean Square Error6653T
R-Squared0.40
Significance0.01
Slope14,209,516
Total Sum of Squares143023.5T

Omega Other Current Liab History

2024248.3 M
2023236.5 M
2022315 M
2021268.4 M
2020225 M
2019312 M
2018272.2 M

About Omega Healthcare Financial Statements

Investors use fundamental indicators, such as Omega Healthcare's Other Current Liab, to determine how well the company is positioned to perform in the future. Although Omega Healthcare's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Other Current Liabilities236.5 M248.3 M

Currently Active Assets on Macroaxis

When determining whether Omega Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Omega Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Omega Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Omega Healthcare Investors Stock:
Check out the analysis of Omega Healthcare Correlation against competitors.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omega Healthcare. If investors know Omega will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omega Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.137
Dividend Share
2.68
Earnings Share
1.36
Revenue Per Share
4.03
Quarterly Revenue Growth
0.14
The market value of Omega Healthcare Inv is measured differently than its book value, which is the value of Omega that is recorded on the company's balance sheet. Investors also form their own opinion of Omega Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Omega Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omega Healthcare's market value can be influenced by many factors that don't directly affect Omega Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omega Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omega Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omega Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.